Presentations
See our latest powerpoint presentation here
Interview with Redeye on Q2 report
30 August 2023
Presentation and Q&A on Directed Share Issue
6 July 2023
Should you have any further questions regarding the directed share issue, feel free to send us an e-mail on ir@fluoguide.com
Interview with Redeye on clinical update
8 June 2023
Presentation at Redeye Growth Day
1 June 2023
Presentation at ABGSC Life Science Summit
30-31 May 2023
Presentation at Sedermeradagen in Stockholm
30 May 2023
Presentation at Redeye Orphan Drugs Event
26 April 2023
Redeye Exclusive interview on Annual Report
28 February 2023
Presentation at Økonomisk Ugebrev Life Science Investor Conference
22 February 2023
Dansk Aktionærforening interview
24 Januar 2023
Presentation at Redeye Fight Cancer Seminar
19 January 2023
Presentation at Redeye Life Science Day 2022
24 November 2022
Presentation at SEB Healthcare Seminar 2022
22 November 2022
Presentation on interim results from phase lla in lung cancer (in Danish)
15 November 2022
Presentation at Redeye Medtech Seminar 2022
26 October 2022
Presentation at Redeye Investor AW in Malmö
16 September 2022
Presentation at the ABGSC Investor Day
13 September 2022
Investor presentation on updated clinical development strategy
25 August 2022
Presentation at the ABGSC Life Science Summit
19 May 2022
Presentation of FG001 results from the first clinical trial in aggressive brain cancer
17 May 2022
Kapital Partner Life Science Seminar
18 May 2022
FluoGuide presenting at Kapital Partner Life Science seminar
Redeye Orphan Drugs Seminar
27 April 2022
Sedermera dagen in Stockholm
25 April 2022
Presentation of directed issue outcome
14 March 2022
Life Science Investor Conference
23 February 2022
Presentation Redeye Initiate 2021
8 December 2021
Presentation ABG Investor day
7 December 2021
Presentation at Redeye Life Science Day
11 November 2021
Life Science konference Økonomiske ugebrev
20 October 2021
FG001 safety data presentation
11 October, 2021
Redeye Investor Forum in Göteborg
16 September, 2021
Pareto Securities 12th Annual Healthcare Conference
2 September 2021